Back to Search
Start Over
Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process.
- Source :
-
Cytotherapy [Cytotherapy] 2019 Mar; Vol. 21 (3), pp. 307-314. Date of Electronic Publication: 2018 Dec 01. - Publication Year :
- 2019
-
Abstract
- Adoptive cell therapy of tumor-infiltrating lymphocytes has shown promise for treatment of refractory melanoma and other solid malignancies; however, challenges to manufacturing have limited its widespread use. Traditional manufacturing efforts were lengthy, cumbersome and used open culture systems. We describe changes in testing and manufacturing that decreased the process cycle time, enhanced the robustness of critical quality attribute testing and facilitated a functionally closed system. These changes have enabled export of the manufacturing process to support multi-center clinical trials.<br /> (Copyright © 2018 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1477-2566
- Volume :
- 21
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Cytotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 30509772
- Full Text :
- https://doi.org/10.1016/j.jcyt.2018.11.004